Ethinyl estradiol and segesterone vaginal ring and Tildrakizumab-asmn Subcutaneous
Determining the interaction of Ethinyl estradiol and segesterone vaginal ring and Tildrakizumab-asmn Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ethinyl estradiol / segesterone
Brand name: Annovera
Synonyms: Ethinyl estradiol and segesterone (vaginal ring), Segesterone Acetate and Ethinyl Estradiol
Generic Name: tildrakizumab
Brand name: Ilumya
Synonyms: Tildrakizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ethinyl estradiol and segesterone vaginal ring-Tilia Fe
- Ethinyl estradiol and segesterone vaginal ring-Tiludronate
- Ethinyl estradiol and segesterone vaginal ring-Timentin
- Ethinyl estradiol and segesterone vaginal ring-Timentin Add-Vantage
- Ethinyl estradiol and segesterone vaginal ring-Timentin Injection
- Ethinyl estradiol and segesterone vaginal ring-Timentin Novaplus
- Tildrakizumab-asmn Subcutaneous-Ethinyl Estradiol, Drospirenone, and Levomefolate
- Tildrakizumab-asmn Subcutaneous-Ethinyl estradiol, folic acid, and levonorgestrel
- Tildrakizumab-asmn Subcutaneous-Ethinyl Estradiol, Norethindrone, and Ferrous Fumarate
- Tildrakizumab-asmn Subcutaneous-Ethiodized oil Injection
- Tildrakizumab-asmn Subcutaneous-Ethiodol
- Tildrakizumab-asmn Subcutaneous-Ethionamide